What a Decade of IPOs in the US Reveal About Nordic Industrial Strengths

Every Nordic country carries a quiet reputation for a specific industry — consumer tech, biotech, heavy industrials. A first look at a decade of US stock listings puts real numbers behind that reputation. Fifteen Nordic-founded companies have listed on a US exchange since 2016, raising roughly $6 billion combined. Sweden accounts for six of the fifteen and well over half the capital, led by Oatly ($1.4B) and Klarna ($1.4B). Denmark follows closely with five listings. Norway has two; Finland and Iceland one, respectively.

Looking closer at this data uncovers a genuine national pattern. Sweden's listings skew consumer-facing — food, fintech, EVs. Denmark's five are dominated by biotech. Norway's two are industrial: offshore drilling and battery manufacturing. Finland's sole completed entry, IQM Quantum Computers, is deep tech; Iceland's, Alvotech, is biosimilars.

Companies choose a US listing for different reasons: raising fresh capital directly, as Klarna and Oatly did; adding a US listing later for a deeper specialized investor base, as Genmab, Calliditas, and Zealand Pharma all did for biotech-specific capital; combining with an already-listed US company, as Cadeler did with Eneti; or a SPAC merger, faster than a traditional IPO, used by Polestar, FREYR, Alvotech, and IQM. Some companies instead stay listed at home and market shares to US institutional buyers without an actual US listing at all — not reflected in the data above, since no US exchange listing occurs.

Outcomes since listing vary as widely as the reasons for it. Olink was acquired by Thermo Fisher, a clean exit; Hemab is up sharply since its 2026 debut; Genmab and Calliditas remain independently listed and growing. FREYR pivoted, relocated to the US, and rebranded as T1 Energy, while Polestar's stock has traded well below its SPAC-era valuation. Zealand Pharma tried the US listing route and reversed it, voluntarily delisting its ADSs in 2022 to consolidate back in Copenhagen. IQM took a different path still, choosing to stay headquartered in Espoo and dual-list rather than relocate.

Three more Nordic companies are already in motion toward the same decision. Oura, following its 2026 restructuring, has confidentially filed for a US IPO. Joe & the Juice's owner General Atlantic has held early discussions with advisers. And Spinnova, a Finnish materials technology company already listed in Helsinki, confidentially filed for a US dual listing this August, targeting at least $15 million. Worth watching alongside a broader, still-unconfirmed question of how this decade's public capital compares to what several of these same companies raised privately beforehand.

If we've missed a listing or gotten a detail wrong, let us know — we'd like to keep this accurate as more Nordic companies consider the path to public.